Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS.

Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS.

Successful radiosensitization requires that tumor cells become more radiosensitive without causing an equivalent reduction in the survival of cells of the surrounding normal tissues. Since tumor cell radiosensitivity can be influenced by RAS oncogene activation, we have hypothesized that inhibition...

Full description

Bibliographic Details
Main Authors:	Cohen-Jonathan, E, Muschel, R, Gillies McKenna, W, Evans, S, Cerniglia, G, Mick, R, Kusewitt, D, Sebti, S, Hamilton, A, Oliff, A, Kohl, N, Gibbs, J, Bernhard, E
Format:	Conference item
Published:	2000

Similar Items

Farnesyltransferase inhibitors as radiation sensitizers.
by: Mckenna, W, et al.
Published: (2002)

Farnesyltransferase inhibitors as radiation sensitizers.
by: Brunner, T, et al.
Published: (2003)

Farnesyltransferase inhibitors.
by: Hahn, S, et al.
Published: (2001)

Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.
by: Brunner, T, et al.
Published: (2003)

The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras.
by: Cohen-Jonathan, E, et al.
Published: (2001)

Farnesyltransferase inhibitors as radiation sensitizers
by: Mckenna, W
Published: (2005)

Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase.
by: Hast, M, et al.
Published: (2009)

Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agents.
by: Fletcher, S, et al.
Published: (2010)

A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer.
by: Hahn, S, et al.
Published: (2002)

C-Raf-1 protein kinase is not essential for Ras transformation of mouse embryo fibroblasts.
by: Gupta, A, et al.
Published: (2003)

HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo.
by: Gupta, A, et al.
Published: (2005)

Down-regulation of Akt signaling with HIV-1 protease inhibitors
by: Gupta, A, et al.
Published: (2005)

A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer.
by: Martin, N, et al.
Published: (2004)

Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.
by: Balasis, M, et al.
Published: (2011)

Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)
by: Gajewski Thomas F, et al.
Published: (2012-12-01)

Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase
by: Lea Weber, et al.
Published: (2021-11-01)

An Integrated Global Analysis of Compartmentalized HRAS Signaling
by: Tapesh Santra, et al.
Published: (2019-03-01)

Potent, Plasmodium-selective farnesyltransferase inhibitors that arrest the growth of malaria parasites: structure-activity relationships of ethylenediamine-analogue scaffolds and homology model validation.
by: Fletcher, S, et al.
Published: (2008)

Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.
by: Gupta, A, et al.
Published: (2003)

Exploring Protoheme IX Farnesyltransferase as an Antimalarial Drug Target
by: Edelen, Samantha Leigh
Published: (2022)

Analyzing the postulated inhibitory effect of Manumycin A on farnesyltransferase
by: Anna Hagemann, et al.
Published: (2022-12-01)

An overview on natural farnesyltransferase inhibitors for efficient cancer therapy
by: Xiaohan Dai, et al.
Published: (2020-01-01)

Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni
by: Alexandra Probst, et al.
Published: (2019-05-01)

A phase I trial of the farnesyltransferase and geranylgeranyltransferase-I inhibitor L-778,123 (L-778) and radiotherapy for locally advanced pancreatic cancer.
by: Martin, N, et al.
Published: (2004)

Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.
by: Van Voorhis, W, et al.
Published: (2007)

Modifying radiosensitivity in tumors: Targeting the Ras-PI-3 kinase pathway.
by: Muschel, R, et al.
Published: (2001)

Inhibition of oncogene-induced inflammatory chemokines using a farnesyltransferase inhibitor
by: Rothstein Jay L, et al.
Published: (2008-02-01)

Phosphorylation of glycogen sythase kinase-3 beta does not contribute to radiation resistance in two cell lines with activation of the Akt pathway
by: Gupta, A, et al.
Published: (2004)

MALDI-MS Analysis of Peptide Libraries Expands the Scope of Substrates for Farnesyltransferase
by: Garrett L. Schey, et al.
Published: (2021-11-01)

Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments
by: Nguyen Thi Ha, et al.
Published: (2020-10-01)

Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria
by: Shao H. Yang, et al.
Published: (2010-02-01)

Mechanism of the exchange reaction in HRAS from multiscale modeling.
by: Abhijeet Kapoor, et al.
Published: (2014-01-01)

The Ras radiation resistance pathway.
by: Gupta, A, et al.
Published: (2001)

Antitumor action of an aminochromene derivative on human - derived lung adenocarcinoma xenograft model
by: E. A. Samishina, et al.
Published: (2019-06-01)

The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer
by: M. P. Smal, et al.
Published: (2015-12-01)

New indazole-indolizine-triazine hybrid molecules with farnesyltransferase inhibitory activity
by: Liliana Ciurlă-Lucescu, et al.
Published: (2024-01-01)

Phenothiazine- and Carbazole-Cyanochalcones as Dual Inhibitors of Tubulin Polymerization and Human Farnesyltransferase
by: Andreea Zubaș, et al.
Published: (2023-06-01)

A Farnesyltransferase Acts to Inhibit Ectopic Neurite Formation in C. elegans.
by: David Carr, et al.
Published: (2016-01-01)

Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers
by: John J. Reiners, et al.
Published: (2023-12-01)

Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice
by: Leah K. Cuddy, et al.
Published: (2022-08-01)